Myovant Sciences’ uterine fibroids combo therapy meets main goal in study

38

Myovant Sciences Ltd said on Tuesday its combination therapy met the main goal of a late-stage study testing the treatment in women with uterine fibroids.

http://feeds.reuters.com/~r/reuters/healthNews/~3/aEB0Svd52bw/myovant-sciences-uterine-fibroids-combo-therapy-meets-main-goal-in-study-idUSKCN1SK1GS